Kampanjeplan CStone Pharmaceuticals
Om selskapet CStone Pharmaceuticals
CStone Pharmaceuticals, биофармацевтическая компания, занимается исследованиями, разработкой и коммерциализацией иммуноонкологических и прецизионных лекарств для удовлетворения неудовлетворенных медицинских потребностей больных раком в Китае и за рубежом. flere detaljer| ISIN | KYG2588M1006 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | hkd |
| Валюта отчета | cny |
| Сайт | https://www.cstonepharma.com |
| Цена ао | 3.84 |
| Prisendring per dag: | +2.13% (3.76) |
|---|---|
| Prisendring per uke: | +11.95% (3.43) |
| Prisendring per måned: | +39.13% (2.76) |
| Prisendring over 3 måneder: | +64.1% (2.34) |
| Prisendring over seks måneder: | +161.22% (1.47) |
| Prisendring per år: | +304.21% (0.95) |
| Prisendring over 3 år: | -11.93% (4.36) |
| Prisendring over 5 år: | -66.49% (11.46) |
| Prisendring siden begynnelsen av året: | +66.96% (2.3) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institusjoner | Volum | Dele, % |
|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 6242500 | 0.49 |
| Vanguard International Stock Index-Total Intl Stock Indx | 5858876 | 0.46 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 1459000 | 0.11 |
| Vanguard Intl Equity Index - Total World Stock Index Fd | 398000 | 0.03 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) China ETF | 117000 | 0.01 |
| Vanguard World Fund-Vanguard ESG International Stock ETF | 80000 | 0.01 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) Emerging Asia Pacific ETF | 40000 | 0 |
| ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
|---|---|---|---|
SPDR S&P China ETF
|
0.00447 | 17.02 | 3.40103 |
| Dimensional Emerging Markets Value ETF | 0.00154 | 17.07 | 4.19508 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0 | 9.39 | 3.09932 |
| 0 | 12.47 | 3.44 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Dr. Jianxin Yang M.D., Ph.D. | CEO and President of R&D | 2.75M | 1964 (61 år) |
| Dr. Ngai Chiu Tse M.D., Ph.D. | Senior VP & Chief Scientific Officer | N/A | 1968 (57 år) |
| Mr. Michael J. Choi M.B.A. | Chief Commercial Officer & Chief Strategy Officer | N/A | 1975 (50 år) |
| Ms. Weicong Ni | Chief Financial Officer | N/A | |
| Ms. Ying Hua Zhang | Head of Operations | ||
| Man Liu | Head of Commercial | ||
| Ms. Mei Yee Yung FCIS, FCS | Joint Company Secretary | 1965 (60 år) |
Adresse: China, Suzhou, C1 Building - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.cstonepharma.com
Nettsted: https://www.cstonepharma.com
